Non-alcoholic fatty liver. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with non-alcoholic fatty liver grade1, 2 and 3 Patients with newly diagnosed fatty liver Candidates for fatty liver treatment
Exclusion criteria
Exclusion criteria: Patient dissatisfaction Rule out the diagnosis of fatty liver Drug intolerance Existence of diabetes, , heart, renal and pulmonary failure, other liver diseases in which fatty liver appears in the picture alcohol consumption antioxidant and vitamins supplements other that vitamin E pregnant and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of lipid profile level before and after cranberry and placebo use. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Perform blood tests.;Determination of serum insulin and fasting glucose levels before and after cranberry and placebo. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Perform blood tests.;Determination of Ultrasound grade before and after cranberry and placebo. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Ultrasound device.;Determination of serum levels of liver enzymes before and after cranberry and placebo. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Perform blood tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences